Patents by Inventor Shanti N. Sawhney

Shanti N. Sawhney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-.alpha.-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity
    Patent number: 5637570
    Abstract: Novel dlsubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-.alpha.-L-xylo-2-hexulofuranosonic acid containing at least one alkyl group at position 1, position 4 being occupied by OH, O-alkylamino or O-alkylaminoheterocyclic moiety, and the OH group at position 6 being replaced by a saturated heterocyclic moiety or aminoalkyl heterocyclic group. These compounds exhibit anti-cancer, anti-inflammatory and/or anti-proliferative activities. Methods of preparation, pharmaceutical compositions containing the compounds and methods of treating cancer, inflammatory and/or autoimmune disorders employing the compounds are described.
    Type: Grant
    Filed: May 9, 1995
    Date of Patent: June 10, 1997
    Assignee: Chemora Pharmochem
    Inventors: Sudershan K. Arora, Manoj K. Gupta, Pushappam Lukos, Ravinder Kumar, Shanti N. Sawhney